STI571: A Sea Change in Cancer Therapeutics or a One Time Event?
By Brian J. Druker, MD
Development of STI571 and Its Use in Chronic Myelogenous Leukemia and Other Malignancies
By Michael J. Mauro, MD, Michael E. O’Dwyer, MD, and Brian J. Druker, MD